WHO VigiBase를 이용한 키메라 항원 수용체 T세포 치료제의 이 상사례 실마리정보 분석

Signal Detection of Chimeric Antigen Receptor T-cell Therapy Using the World Health Organization VigiBase Database
  • 여송현; 
  • 이주원; 
  • 유승훈; 
  • 임찬순; 
  • 양혜림; 
  • ... 정선영

초록

This study aimed to characterize adverse event reports associated with chimeric antigen receptor T-cell (CAR-T) therapy and to identify potential safety signals using the World Health Organization (WHO) global pharmacovigilance database. Methods: Individual case safety reports submitted to WHO VigiBase up to March 2025 were analyzed. Disproportionality analyses were performed by comparing reports involving CAR-T therapies with those involving Non-CAR-T drugs used as second-line or later treatments for hematologic malignancies, using reporting odds ratios, proportional reporting ratios, and information components. Detected signals were reviewed against product labeling approved by the Korean Ministry of Food and Drug Safety and the U.S. Food and Drug Administration. Results: Among 499,000 reports included in the analysis, 2,563 (0.51%) were associated with CAR-T therapy. A total of 103 preferred term-level safety signals were identified, predominantly involving neurological and infection-related events. Several high-disproportionality signals, including eosinophilic cellulitis, tumour pseudoprogression, human herpesvirus 6 encephalitis, and cardiorenal syndrome, among others, were not specified in current product labels. Conclusion: This study identified safety signals associated with CAR-T in real-world practice, confirming known adverse events and suggesting additional neurological and infection-related events beyond current product labeling. These findings highlight the need for ongoing pharmacovigilance and further clinical evaluation.

키워드

Chimeric antigen receptor T-cell therapy; Signal detection; Pharmacovigilance; Adverse event
제목
WHO VigiBase를 이용한 키메라 항원 수용체 T세포 치료제의 이 상사례 실마리정보 분석
제목 (타언어)
Signal Detection of Chimeric Antigen Receptor T-cell Therapy Using the World Health Organization VigiBase Database
저자
여송현; 이주원; 유승훈; 임찬순; 양혜림; 정선영
DOI
10.56142/perm.26.0012
발행일
2026-09
유형
Y
저널명
Pharmacoepidemiology and Risk Management
권
18
호
2
페이지
118 ~ 134